Stelac Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History

Stelac Advisory Services’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,367	Closed	-$713K	–	156
2023 Q2	$713K	Sell	1,367 -78	-5%	-$42.1K	0.32%	58
2023 Q1	$833K	Sell	1,445 -425	-23%	-$240K	0.36%	44
2022 Q4	$1.03M	Buy	1,870 +105	+6%	+$55.6K	0.47%	44
2022 Q3	$895K	Hold	1,765	–	–	0.41%	45
2022 Q2	$959K	Buy	1,765 +1,207	+216%	+$664K	0.39%	46
2022 Q1	$330K	Sell	558 -1,172	-68%	-$673K	0.12%	68
2021 Q4	$1.15M	Buy	1,730 +116	+7%	+$72.4K	0.31%	50
2021 Q3	$922K	Sell	1,614 -274	-15%	-$150K	0.25%	65
2021 Q2	$952K	Buy	1,888 +1,303	+223%	+$615K	0.22%	83
2021 Q1	$267K	Buy	585 +200	+52%	+$95.5K	0.1%	135
2020 Q4	$179K	Sell	385 -24	-6%	-$11.3K	0.05%	188
2020 Q3	$181K	Buy	+409	New	+$169K	0.06%	139

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Stelac Advisory Services's TMO Position: Q3 2023 in Review

Stelac Advisory Services sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 1,367 shares — an estimated $713K sold.

Stelac Advisory Services first reported a position in TMO in Q3 2020 and held it in 12 quarters. The position peaked at $1.15M in Q4 2021. 2,364 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

Stelac Advisory Services reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
Stelac Advisory Services sold 1,367 Thermo Fisher Scientific shares in Q3 2023, an estimated $713K.
Stelac Advisory Services first reported a position in Thermo Fisher Scientific in Q3 2020 and held it in 12 quarters.
Stelac Advisory Services's Thermo Fisher Scientific position peaked at $1.15M in Q4 2021.
2,364 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Stelac Advisory Services's 13F filing for Q3 2023, filed 13 Nov 2023.